GenMark Diagnostics Plans to Expand Test Menu, Develop Automated Next-Gen System | GenomeWeb

By Justin Petrone

GenMark Diagnostics is planning to introduce a number of array-based tests in coming years and is working on an automated, next-generation instrument, according to a May 13 filing with the US Securities and Exchanges Commission.

The filing came days after the firm reported that its first-quarter sales nearly doubled over the prior year, driven by an increase in instrument placements.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.